Holdings of JNL/Mellon Healthcare Sector Fund
JNL Series Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 2.7B $ including 2.7B $ in equities, 99.6 %
- Positions
- 138 in 4 countries
- Top ten
- 54.4 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 329,819 | 395.6M $ | 14.77 % |
| 2 | Johnson & Johnson | 991,814 | 251.9M $ | 9.41 % |
| 3 | AbbVie Inc | 727,412 | 183M $ | 6.84 % |
| 4 | UnitedHealth Group Inc | 373,374 | 155.2M $ | 5.79 % |
| 5 | Merck & Co Inc | 988,863 | 127.1M $ | 4.75 % |
| 6 | Amgen Inc | 221,467 | 80.2M $ | 2.99 % |
| 7 | Thermo Fisher Scientific Inc | 153,110 | 76.8M $ | 2.87 % |
| 8 | Abbott Laboratories | 716,363 | 65M $ | 2.43 % |
| 9 | Gilead Sciences Inc | 511,168 | 64.6M $ | 2.41 % |
| 10 | Intuitive Surgical Inc | 145,324 | 57.8M $ | 2.16 % |
| 11 | Pfizer Inc | 2,334,839 | 56.2M $ | 2.10 % |
| 12 | CVS Health Corp | 520,674 | 53.9M $ | 2.01 % |
| 13 | Vertex Pharmaceuticals Inc | 104,429 | 51.9M $ | 1.94 % |
| 14 | Danaher Corp | 265,411 | 50.6M $ | 1.89 % |
| 15 | Bristol-Myers Squibb Co | 838,333 | 48.3M $ | 1.80 % |
| 16 | Stryker Corp | 148,881 | 46.9M $ | 1.75 % |
| 17 | Medtronic PLC | 528,396 | 41.3M $ | 1.54 % |
| 18 | McKesson Corp | 49,525 | 37.4M $ | 1.40 % |
| 19 | Elevance Health Inc | 86,162 | 33.3M $ | 1.24 % |
| 20 | Cigna Group/The | 104,750 | 28.9M $ | 1.08 % |
| 21 | Boston Scientific Corp | 608,931 | 26M $ | 0.97 % |
| 22 | Regeneron Pharmaceuticals Inc | 41,489 | 25.9M $ | 0.97 % |
| 23 | HCA Healthcare Inc | 61,969 | 24.2M $ | 0.90 % |
| 24 | Cardinal Health Inc | 96,398 | 22.9M $ | 0.86 % |
| 25 | Cencora Inc | 79,561 | 22.5M $ | 0.84 % |
| 26 | Edwards Lifesciences Corp | 228,567 | 20.7M $ | 0.77 % |
| 27 | Humana Inc | 49,539 | 19.7M $ | 0.73 % |
| 28 | Becton Dickinson & Co | 113,409 | 17.2M $ | 0.64 % |
| 29 | ALNYLAM PHARMACEUTICALS INC | 54,660 | 16.5M $ | 0.61 % |
| 30 | IDEXX Laboratories Inc | 31,184 | 16.4M $ | 0.61 % |
| 31 | Agilent Technologies Inc | 117,502 | 15.6M $ | 0.58 % |
| 32 | NATERA INC | 56,220 | 15.3M $ | 0.57 % |
| 33 | Waters Corp | 40,364 | 15.1M $ | 0.57 % |
| 34 | REVOLUTION MEDICINES INC | 75,980 | 14.2M $ | 0.53 % |
| 35 | IQVIA Holdings Inc | 67,991 | 13.1M $ | 0.49 % |
| 36 | Biogen Inc | 60,413 | 13.1M $ | 0.49 % |
| 37 | Centene Corp | 203,017 | 13M $ | 0.49 % |
| 38 | Zoetis Inc | 172,853 | 12.4M $ | 0.46 % |
| 39 | GE HealthCare Technologies Inc | 187,128 | 12M $ | 0.45 % |
| 40 | ResMed Inc | 59,878 | 11.7M $ | 0.44 % |
| 41 | Illumina Inc | 62,829 | 11M $ | 0.41 % |
| 42 | Veeva Systems Inc | 61,663 | 10.9M $ | 0.41 % |
| 43 | Dexcom Inc | 159,151 | 10.7M $ | 0.40 % |
| 44 | Mettler-Toledo International Inc | 8,375 | 10.7M $ | 0.40 % |
| 45 | West Pharmaceutical Services Inc | 29,018 | 10.4M $ | 0.39 % |
| 46 | MODERNA INC | 146,197 | 10.2M $ | 0.38 % |
| 47 | Quest Diagnostics Inc | 45,587 | 9.7M $ | 0.36 % |
| 48 | Labcorp Holdings Inc | 33,766 | 9.5M $ | 0.35 % |
| 49 | Insmed Inc | 88,484 | 9.4M $ | 0.35 % |
| 50 | STERIS PLC | 40,695 | 8.6M $ | 0.32 % |
| 51 | ROYALTY PHARMA PLC | 152,104 | 8.5M $ | 0.32 % |
| 52 | United Therapeutics Corp | 15,538 | 8.4M $ | 0.31 % |
| 53 | GUARDANT HEALTH INC | 52,402 | 7.9M $ | 0.29 % |
| 54 | Incyte Corp | 68,974 | 7.8M $ | 0.29 % |
| 55 | VIATRIS INC | 464,466 | 7.4M $ | 0.28 % |
| 56 | Roivant Sciences Ltd | 205,898 | 7.3M $ | 0.27 % |
| 57 | Neurocrine Biosciences Inc | 41,171 | 6.9M $ | 0.26 % |
| 58 | Zimmer Biomet Holdings Inc | 79,940 | 6.9M $ | 0.26 % |
| 59 | TENET HEALTHCARE CORP | 35,245 | 6.6M $ | 0.25 % |
| 60 | JAZZ PHARMACEUTICALS PLC | 25,780 | 6.2M $ | 0.23 % |
| 61 | Cooper Cos Inc/The | 80,531 | 5.8M $ | 0.22 % |
| 62 | IONIS PHARMACEUTICALS INC | 67,846 | 5.4M $ | 0.20 % |
| 63 | Revvity Inc | 46,177 | 5.1M $ | 0.19 % |
| 64 | Exelixis Inc | 93,314 | 5.1M $ | 0.19 % |
| 65 | Bridgebio Pharma Inc | 67,637 | 5M $ | 0.19 % |
| 66 | Medpace Holdings Inc | 9,333 | 4.9M $ | 0.18 % |
| 67 | Penumbra Inc | 15,586 | 4.9M $ | 0.18 % |
| 68 | Molina Healthcare Inc | 21,196 | 4.8M $ | 0.18 % |
| 69 | Align Technology Inc | 28,661 | 4.8M $ | 0.18 % |
| 70 | ELANCO ANIMAL HEALTH INC | 195,331 | 4.8M $ | 0.18 % |
| 71 | Solventum Corp | 60,590 | 4.7M $ | 0.17 % |
| 72 | Bio-Techne Corp | 64,928 | 4.6M $ | 0.17 % |
| 73 | BioMarin Pharmaceutical Inc | 79,448 | 4.5M $ | 0.17 % |
| 74 | Baxter International Inc | 211,820 | 4.5M $ | 0.17 % |
| 75 | Charles River Laboratories International Inc | 19,649 | 4.5M $ | 0.17 % |
| 76 | CYTOKINETICS INC | 51,115 | 4.4M $ | 0.16 % |
| 77 | Insulet Corp | 28,516 | 4.3M $ | 0.16 % |
| 78 | BRIGHTSPRING HEALTH SERVICES INC | 61,840 | 4.3M $ | 0.16 % |
| 79 | Axsome Therapeutics Inc | 17,328 | 4.2M $ | 0.16 % |
| 80 | Madrigal Pharmaceuticals Inc | 7,890 | 4.2M $ | 0.16 % |
| 81 | Medline Inc | 107,033 | 4.2M $ | 0.16 % |
| 82 | Encompass Health Corp | 40,810 | 4.1M $ | 0.15 % |
| 83 | Arrowhead Pharmaceuticals Inc | 50,355 | 4.1M $ | 0.15 % |
| 84 | Krystal Biotech Inc | 10,437 | 3.9M $ | 0.14 % |
| 85 | Ensign Group Inc/The | 24,075 | 3.9M $ | 0.14 % |
| 86 | Halozyme Therapeutics Inc | 49,049 | 3.8M $ | 0.14 % |
| 87 | Globus Medical Inc | 46,147 | 3.6M $ | 0.14 % |
| 88 | Corcept Therapeutics Inc | 40,188 | 3.5M $ | 0.13 % |
| 89 | Alkermes PLC | 65,083 | 3.4M $ | 0.13 % |
| 90 | APTARGROUP INC | 26,277 | 3.3M $ | 0.12 % |
| 91 | TG THERAPEUTICS INC | 59,718 | 3.3M $ | 0.12 % |
| 92 | Glaukos Corp | 23,272 | 3.3M $ | 0.12 % |
| 93 | Henry Schein Inc | 38,704 | 3.2M $ | 0.12 % |
| 94 | DaVita Inc | 14,207 | 3.2M $ | 0.12 % |
| 95 | Universal Health Services Inc | 21,146 | 3.1M $ | 0.12 % |
| 96 | HealthEquity Inc | 34,448 | 3.1M $ | 0.12 % |
| 97 | VAXCYTE INC | 52,683 | 3.1M $ | 0.11 % |
| 98 | Repligen Corp | 21,851 | 3M $ | 0.11 % |
| 99 | Praxis Precision Medicines Inc | 8,897 | 3M $ | 0.11 % |
| 100 | Lantheus Holdings Inc | 26,817 | 3M $ | 0.11 % |
Sector breakdown
- Health care 87.9 %
- Technology 0.4 %
- Unattributed 11.7 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 99.3 %
- Ireland 0.4 %
- Bermuda 0.3 %
- Switzerland 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 134 | 2.6B $ | 99.29 % |
| 2 | Ireland | 2 | 9.6M $ | 0.36 % |
| 3 | Bermuda | 1 | 7.3M $ | 0.27 % |
| 4 | Switzerland | 1 | 2.1M $ | 0.08 % |
Cite this page
Titelia. "Holdings of JNL/Mellon Healthcare Sector Fund". https://titelia.com/en/funds/S000068125